V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009111 | 220021786 | null | 60 | null | null | 2014-11-15 | OCTREOTIDE | null | null | 220035947 | FLUDARABINE + MELPHALAN |
| 220009112 | 220003683 | 1.92 | 72.6 | Palliative (P) | 2014-11-22 | 2014-12-03 | Carbo F | 2 | N | 220035951 | CAPECITABINE |
| 220009113 | 220003684 | 1.76 | 72.85 | Curative (C) | null | 2014-03-21 | BOSUTINIB | N | N | 220035956 | LENALIDOMIDE |
| 220009114 | 220003684 | 1.54 | null | Curative (C) | 2017-02-03 | 2017-02-03 | LENALIDOMIDE | Y | null | 220035956 | CYCLOPHOSPHAMIDE |
| 220009115 | 220003685 | 1.63 | null | Palliative (P) | 2016-12-20 | 2017-01-15 | CISPLATIN + FLUOROURACIL | N | N | 220035959 | TEMOZOLOMIDE |
| 220009116 | 220003686 | 1.63 | 0 | Palliative (P) | 2017-03-25 | 2017-04-12 | Mitoxantrone | N | N | 220035962 | PACLITAXEL |
| 220009117 | 220003686 | null | null | Palliative (P) | 2016-12-25 | 2016-12-26 | Triple / Double Intrathecal Therapy | N | N | 220035962 | VEMURAFENIB |
| 220009118 | 220003686 | 1.61 | 20.9 | Palliative (P) | 2013-11-12 | 2013-11-15 | Carboplatin + Liposomal Doxorubicin | N | Y | 220035962 | CISPLATIN + ETOPOSIDE |
| 220009119 | 220003686 | 1.69 | 65.8 | Adjuvant (A) | 2017-02-17 | 2017-02-28 | Capecitabine | 02 | N | 220035962 | CLADRIBINE |
| 220009120 | 220003687 | 1.76 | 14.4 | Palliative (P) | 2015-02-16 | 2015-11-03 | CAPECITABINE + CARBOPLATIN | N | N | 220035969 | DABRAFENIB + TRAMETINIB |
| 220009121 | 220003688 | 1.61 | 48.9 | Palliative (P) | 2016-09-05 | 2016-09-05 | ECarboX | N | null | 220035971 | VEMURAFENIB |
| 220009122 | 220003689 | 1.6 | 76.4 | Palliative (P) | 2014-12-20 | 2014-12-24 | Cyclophosphamide High Dose | 2 | N | 220035973 | IRINOTECAN + MDG |
| 220009123 | 220012001 | 1.74 | null | null | 2016-04-12 | 2016-04-23 | Cisplatin + Pemetrexed | N | N | 220035974 | OCTREOTIDE |
| 220009124 | 220012001 | null | 124.8 | Palliative (P) | null | 2014-05-07 | Triple / Double Intrathecal Therapy | Y | N | 220035974 | CAPECITABINE + CISPLATIN |
| 220009125 | 220012001 | null | 95 | Neo-adjuvant (N) | 2014-07-29 | 2014-07-29 | UKALL14- Ph 1 Induction | 02 | N | 220035974 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009126 | 220012001 | null | 130 | Palliative (P) | 2015-05-08 | 2015-05-10 | BOSUTINIB | 02 | N | 220035974 | CISPLATIN + ETOPOSIDE |
| 220009127 | 220003690 | 1.56 | 108.7 | Palliative (P) | 2014-05-11 | 2014-05-19 | RUXOLITINIB | N | N | 220035983 | FLUOROURACIL |
| 220009128 | 220003691 | 0.62 | 75 | Palliative (P) | 2015-11-14 | 2015-11-20 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | null | null | 220035984 | ECF |
| 220009129 | 220003691 | 1.68 | 20.9 | Not known (9) | 2013-04-15 | 2013-05-10 | OCTREOTIDE | N | N | 220035984 | CISPLATIN |
| 220009130 | 220003691 | 1.49 | 88.9 | Disease modification (D) | 2017-06-19 | 2017-06-19 | IPILIMUMAB + NIVOLUMAB | N | N | 220035984 | MELPHALAN |
| 220009131 | 220003691 | 1.85 | 96.5 | Palliative (P) | 2016-08-01 | 2016-08-07 | BEP 3 day | 2 | null | 220035984 | RUXOLITINIB |
| 220009132 | 220003691 | 1.48 | null | null | 2014-05-12 | 2014-05-16 | OCTREOTIDE | Y | N | 220035984 | SUNITINIB |
| 220009137 | 220003693 | 1.65 | 0 | Palliative (P) | 2015-12-30 | 2015-12-30 | NHL 2003 Gp B COP | N | N | 220036006 | IPILIMUMAB + NIVOLUMAB |
| 220009138 | 220003694 | 1.69 | 91 | Curative (C) | 2014-03-23 | 2014-05-25 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | Y | 220036007 | SPIRIT TRIAL |
| 220009139 | 220003695 | 1.55 | 0 | Not known (9) | 2013-05-17 | 2013-05-17 | Capecitabine | 2 | N | 220036011 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009140 | 220003695 | 1.72 | 91 | Curative (C) | 2014-06-03 | 2014-06-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 220036011 | BOSUTINIB |
| 220009141 | 220003696 | null | null | Palliative (P) | null | 2014-04-01 | CYTARABINE + ETOPOSIDE + IDARUBICIN | N | N | 220036013 | TEMOZOLOMIDE |
| 220009142 | 220003696 | null | 56.25 | null | 2014-01-13 | 2014-01-27 | Fludarabine + Melphalan RIC Allo | Y | N | 220036013 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009143 | 220003696 | 1.7 | 81.6 | Palliative (P) | 2014-12-11 | 2014-12-15 | Capecitabine + Cisplatin + RT | 02 | N | 220036013 | CETUXIMAB + IRINOTECAN + MDG |
| 220009144 | 220003696 | 1.82 | 6.5 | Palliative (P) | 2015-06-07 | 2016-06-25 | PONATINIB | N | N | 220036013 | CAPECITABINE + CISPLATIN |
| 220009145 | 220003697 | 1.87 | 0 | Palliative (P) | 2017-11-05 | 2017-11-06 | THALIDOMIDE | 02 | N | 220036018 | CYTARABINE INTRATHECAL |
| 220009146 | 220003698 | 1.68 | 85.4 | Palliative (P) | 2013-06-26 | 2013-06-26 | Fludarabine + Melphalan RIC Allo | 02 | N | 220036019 | PACLITAXEL |
| 220009147 | 220003699 | 1.7 | null | Palliative (P) | 2013-03-11 | 2013-03-18 | IDARUBICIN + MITOXANTRONE + Tretinoin | 2 | N | 220036020 | IRINOTECAN + MDG |
| 220009148 | 220003700 | 1.72 | 57.7 | Palliative (P) | 2016-05-25 | 2016-05-25 | Paclitaxel 7 day | N | N | 220036022 | CHOP R |
| 220009149 | 220003700 | 1.6 | 67 | Adjuvant (A) | 2013-11-15 | 2014-01-03 | Triple / Double Intrathecal Therapy | 02 | N | 220036022 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009150 | 220003700 | 1.7 | 89.5 | Palliative (P) | 2015-11-06 | 2015-11-06 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 220036022 | IPILIMUMAB + NIVOLUMAB |
| 220009151 | 220003700 | null | 131.2 | Palliative (P) | 2013-08-22 | 2013-08-28 | CARBOPLATIN + RT | N | N | 220036022 | BENDAMUSTINE + RITUXIMAB |
| 220009152 | 220003701 | null | 111 | Palliative (P) | null | 2014-07-20 | Bortezomib + MELPHALAN | null | null | 220036036 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 220009153 | 220003702 | 1.43 | 61 | Palliative (P) | 2014-02-18 | 2014-02-18 | Triple Intrathecal | N | N | 220036037 | LENALIDOMIDE |
| 220009154 | 220003702 | 1.61 | 64.8 | Curative (C) | 2017-03-09 | 2017-03-09 | Cyclophosphamide TBI Allograft | 2 | N | 220036037 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009155 | 220003703 | 1.71 | 99 | Curative (C) | 2013-06-30 | 2013-07-05 | Docetaxel | N | Y | 220036041 | CYTARABINE INTRATHECAL |
| 220009156 | 220003704 | 1.71 | 60.5 | Curative (C) | 2013-03-17 | 2013-03-17 | LENALIDOMIDE | N | N | 220036043 | CYTARABINE + MITOXANTRONE |
| 220009157 | 220003705 | 1.67 | null | Palliative (P) | 2017-12-19 | 2017-12-19 | Irinotecan + Modified De Gramont | N | N | 220036046 | ECARBOX |
| 220009158 | 220003706 | 1.8 | 0 | Palliative (P) | 2014-10-13 | 2014-10-14 | Ipilimumab | 01 | N | 220036048 | FCARBOST |
| 220009159 | 220003706 | 1.64 | 66.1 | Palliative (P) | 2013-04-29 | 2013-04-30 | ROMAZA TRIAL | 2 | N | 220036048 | IPILIMUMAB |
| 220009160 | 220003706 | 1.85 | 115.5 | Curative (C) | 2016-12-24 | 2016-12-24 | Methotrexate intrathecal | 02 | N | 220036048 | ATG + BUSULFAN + FLUDARABINE |
| 220009161 | 220003707 | null | 24.4 | Curative (C) | 2017-09-03 | 2017-09-24 | Arsenic Trioxide (consolidation) | N | N | 220036052 | MITOXANTRONE |
| 220009162 | 220003708 | 1.89 | 72 | Palliative (P) | 2013-05-09 | 2013-05-17 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 220036053 | ECARBOX |
| 220009163 | 220003709 | 1.67 | 69.55 | Palliative (P) | 2015-04-22 | 2015-04-23 | Cytarabine intrathecal | 2 | null | 220036056 | CARBOPLATIN + PEMETREXED |
| 220009164 | 220003710 | null | 73 | Palliative (P) | 2015-07-08 | 2015-07-29 | AML LI-1 Trial | N | N | 220036057 | CISPLATIN + DOCETAXEL + FLUOROURACIL |